Skip to main content
An official website of the United States government

Pre-Cancer Atlas (PCA)

A tumor (yellow) is shown in the background. Components within the microenvironment are overlaid on the tumor, including a dendritic cell (pink), a T-cell (blue), a fibroblast (purple and pink), a natural killer cell (dark blue), a regulatory t cell (aqua), blood vessels (red), a macrophage cell (red with a yellow center), and a myeloid cell (green).

The Pre-cancer Atlas (PCA) Research Centers are part of the Human Tumor Atlas Network (HTAN). HTAN, an NCI-collaborative program, is constructing multi-dimensional atlases of the cellular, morphological, molecular, and spatial features of human cancers and their surrounding microenvironments over time.

The atlases being created by HTAN describe important changes during cancer progression, such as the transition of precancers to malignant tumors, the evolution of metastatic cancer, and the development of treatment resistance.

HTAN is supported by the NCI Division of Cancer Prevention (DCP), NCI Division of Biology (DCB), the NCI Division of Cancer Treatment and Diagnosis (DCTD), and the NCI Center for Strategic Science Initiatives (CSSI).

On This Page

  • All Heading 2s will automatically be pulled in to this list.
  • Do not edit the content on this template.

About Pre-Cancer Atlas

The Pre-cancer Atlas (PCA) Research Centers, along with the Human Tumor Atlas (HTA) Research Centers and a Data Coordinating Center (DCC), make up HTAN. Each PCA Research Center will create a 2D/3D precancer atlas of a pre-cancerous lesion, focusing on how it changes into cancer.

PCA Research Centers have three major tasks:

  • Collecting, processing, and labeling biospecimens.
  • Studying the molecular, cellular, and spatial details of the lesions.
  • Analyzing and modeling the data.

PCA Research Centers will collaborate with other components of HTAN to make the data and analytical tools available to the research community.

Grantee Details

PI Name Sort descending PI Organization Title Grant Number Program Official
Demb, Joshua Brian

University Of California, San Diego
United States

Optimal early colorectal cancer screening initiation 4R00CA267181-03 Claire Zhu, Ph.D.
Demehri, Shadmehr

Massachusetts General Hospital
United States

Immunosurveillance of breast glands with oncogenic germline mutations 5UG3CA290300-02 Altaf Mohammed, Ph.D.
Deng, Gary E

University Of California-Irvine
United States

Acupuncture to Improve Outcomes in Patients with Sepsis: a Randomized Controlled Trial 7R21CA286330-03 Goli Samimi, Ph.D., M.P.H.
Deng, Jie

University Of Pennsylvania
United States

Placebo-Controlled Phase II Randomized Clinical Trial of Photobiomodulation Therapy in Head and Neck Cancer Survivors with Chronic Lymphedema 1R01CA289307-01A1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Deng, Youping

University Of Hawaii At Manoa
United States

Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms 5R01CA230514-05 Christos Patriotis, Ph.D., M.Sc.
Dhakal, Soma

Virginia Commonwealth University
United States

Single-Molecule High-Confidence Detection of miRNA Cancer Biomarkers 5R61CA278445-03 Christos Patriotis, Ph.D., M.Sc.
Diaz, Juan Sebastian Gomez

University Of California At Davis
United States

A miniaturized neural network enabled nanoplasmonic spectroscopy platform for label-free cancer detection in biofluids 3R01CA273253-03S1 Nicholas Hodges, Ph.D.
Dickinson, Sally E

University Of Arizona
United States

Investigating novel targets for topical immunoprevention of keratinocytic skin cancer 1UG3CA290443-01A1 Altaf Mohammed, Ph.D.
Digirolamo, Gregory James

Univ Of Massachusetts Med Sch Worcester
United States

Increasing Nodule Detection in Lung Cancer by Non-Conscious Detection of "Missed" Nodules and Machine Learning 5R01CA269903-04
Doescher, Mark P

University Of Oklahoma Hlth Sciences Ctr
United States

Oklahoma Tribal, Rural, Urban Cancer Screening Trial ACCESS Hub 3UG1CA287044-02S1 Elyse LeeVan, M.D., M.P.H.
Doolittle, Gary C.

University Of Kansas Medical Center
United States

The University of Kansas Cancer Center's- MCA Rural NCORP- extension 3UG1CA239767-06S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Doolittle, Gary C.

University Of Kansas Medical Center
United States

The University of Kansas Cancer Center's- MCA Rural NCORP- extension 3UG1CA239767-06S1 Brandy Heckman-Stoddard, Ph.D., M.P.H.
Drake, Richard R.

Medical University Of South Carolina
United States

Targeted Isolation and Identification of Sialylated Glycoproteins in Cancer Tissues, Cells and Biofluids 5R33CA267226-03
Drescher, Charles

Swedish Medical Center, First Hill
United States

The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site 3UG1CA189953-11S1 Vanessa A. White, M.P.H.
Drescher, Charles

Swedish Medical Center, First Hill
United States

The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site 3UG1CA189953-11S1 Vanessa A. White, M.P.H.